Covered recipient · General Payments record
GABRIEL MARTIN IBARRA
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$2,889.59
- Reported across 108 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $332.70 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Corium, Inc. | $145.48 | 13 |
| Novo Nordisk AS | $92.57 | 1 |
| ABBVIE INC. | $60.39 | 3 |
| Acerta Pharma LLC | $20.47 | 1 |
| Lilly USA, LLC | $13.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.80 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107379818 | CMS |
| ABBVIE INC. | $15.05 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107379820 | CMS |
| ABBVIE INC. | $27.54 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107379822 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.47 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104617396 | CMS |
| Corium, LLC | $11.61 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100120024 | CMS |
| Corium, LLC | $8.16 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100126324 | CMS |
| Corium, LLC | $17.38 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100105943 | CMS |
| Corium, LLC | $7.97 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100126682 | CMS |
| Corium, LLC | $14.44 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100114314 | CMS |
| Corium, LLC | $6.74 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100129242 | CMS |
| Corium, LLC | $11.52 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100120152 | CMS |
| Corium, LLC | $12.28 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100158975 | CMS |
| Corium, LLC | $8.63 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100152441 | CMS |
| Corium, LLC | $10.06 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100155027 | CMS |
| Corium, LLC | $11.38 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100157371 | CMS |
| Corium, LLC | $11.68 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100157903 | CMS |
| Corium, LLC | $13.63 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100161491 | CMS |
| Lilly USA, LLC | $13.79 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135680735 | CMS |
| Novo Nordisk Inc | $92.57 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100425449 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.